The leading cancer treatment and research institution in New York City has appointed physician and researcher George J. Bosl as its first Ombudsperson. “The creation of the position of ombudsperson represents an important milestone in MSK’s ongoing effort to balance the need to collaborate with outside industry to further scientific research with our institution’s commitment to preserving the objectivity and integrity of our work, as well as our commitment to transparency,” said Senior VP and Chief Risk Officer Debra Berns.
“Dr. Bosl’s sterling personal and professional reputation makes him an ideal choice to spearhead this position and ensure that our institution stays true to its founding mission to advance cancer care.” The new Ombuds office was recommended by MSK’s Conflict of Interest Task Force and is one of several initiatives the center will take in the coming months.
Bosl served as chair of MSK's Department of Medicine for two decades. He graduated from John Carroll University and earned his MD at Creighton University School of Medicine. He did his training at The New York Hospital, Memorial Sloan Kettering Cancer Center, and the University of Minnesota. (MSKCC Blog; Wikipedia.)